Copyright
©The Author(s) 2016.
World J Clin Pediatr. Feb 8, 2016; 5(1): 95-101
Published online Feb 8, 2016. doi: 10.5409/wjcp.v5.i1.95
Published online Feb 8, 2016. doi: 10.5409/wjcp.v5.i1.95
Table 1 Patient characteristics
Age (mo) | Gender | Symptoms at diagnosis | Lesion location | Degree of SGE (Cotton scale) | Treatment | Outcomes | |
1 | 2 | F | Stridor | Subglottic | II | Corticosteroids | Asymptomatic |
2 | 3 | F | Stridor | Glottis and subglottic | Interferon, corticosteroids | Asymptomatic | |
3 | 1 | M | Stridor | Subglottic | II | Corticosteroids | Asymptomatic |
4 | 1 | F | Stridor | Subglottis and trachea | I | Resection and cricothyroidotomy | Asymptomatic |
5 | 1 | M | Stridor, dyspnea | Supraglottis and subglottis | III | Laryngotracheoplasty | Dysphonia |
6 | 14 | M | Stridor, dyspnea | Subglottic | III | Corticosteroids, laser, resection and cricothyroidotomy | Asymptomatic |
7 | 27 | F | Stridor | Subglottic | II | Laser, laryngotracheoplasty | Exitus |
8 | 2 | F | Stridor, dyspnea | Subglottic | III | Laryngotracheoplasty | Dysphonia |
9 | 4 | F | stridor, dyspnea | Subglottic | III | Corticosteroids, laryngotracheoplasty | Dysphonia |
10 | 3 | F | Stridor, dyspnea | Subglottic | III | Laryngotracheoplasty | Transitory stridor |
11 | 5 | F | Stridor, dyspnea | Subglottic | III | Laryngotracheoplasty | Asymptomatic |
12 | 16 | M | Stridor, dyspnea | Glottis and subglottic | I | Corticosteroids | Asymptomatic |
13 | 5 | F | Stridor, dyspnea | Subglottic | III | Corticosteroids, resection and cricothyroidotomy | Transitory stridor |
14 | 3 | F | Stridor | Subglottis and trachea | I | Corticosteroids, laryngotracheoplasty | Asymptomatic |
14 | 19 | M | Stridor | Subglottic | I | Propranolol | Exitus |
16 | 5 | F | Stridor | Supraglottis | - | Propranolol | Asymptomatic |
17 | 26 | M | Stridor | Subglottic | I | Propranolol | Asymptomatic |
18 | 5 | F | Stridor, dyspnea | Subglottic | III | Corticosteroids, propranolol | Asymptomatic |
19 | 3 | F | Stridor | Subglottic | II | Propranolol | Asymptomatic |
20 | 3 | M | Stridor | Subglottic | I | Propranolol | Asymptomatic |
21 | 2 | F | Stridor | Subglottic | I | Propranolol | Asymptomatic |
22 | 2 | F | Stridor | Subglottic | I | Propranolol | Asymptomatic |
23 | 3 | F | Stridor | Subglottic | I | Propranolol | Asymptomatic |
- Citation: Vivas-Colmenares GV, Fernandez-Pineda I, Lopez-Gutierrez JC, Fernandez-Hurtado MA, Garcia-Casillas MA, Matute de Cardenas JA. Analysis of the therapeutic evolution in the management of airway infantile hemangioma. World J Clin Pediatr 2016; 5(1): 95-101
- URL: https://www.wjgnet.com/2219-2808/full/v5/i1/95.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v5.i1.95